Report Cover

Global Biosimilars/Follow-on-Biologics Market Growth 2020-2025


According to this study, over the next five years the Biosimilars/Follow-on-Biologics market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Biosimilars/Follow-on-Biologics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilars/Follow-on-Biologics market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Biosimilars/Follow-on-Biologics, covering the supply chain analysis, impact assessment to the Biosimilars/Follow-on-Biologics market size growth rate in several scenarios, and the measures to be undertaken by Biosimilars/Follow-on-Biologics companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
    Human Growth Hormone
    Erythropoietin
    Monoclonal Antibodies
    Insulin
    Interferon
    Granulocyte-Colony Stimulating Factor
    Peptide
    Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
    Blood Disorders
    Oncology Diseases
    Chronic and Autoimmune Diseases
    Growth Hormone Deficiencies
    Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    Novartis
    Genentech (Roche Group)
    Synthon Pharmaceuticals
    LG Life Sciences
    Celltrion
    Teva Pharmaceutical Industries
    Merck Group
    Biocon
    Biogen idec, Inc.
    Hospira

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global Biosimilars/Follow-on-Biologics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of Biosimilars/Follow-on-Biologics market by identifying its various subsegments.
    Focuses on the key global Biosimilars/Follow-on-Biologics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Biosimilars/Follow-on-Biologics with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Biosimilars/Follow-on-Biologics submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Biosimilars/Follow-on-Biologics Consumption 2015-2025
        2.1.2 Biosimilars/Follow-on-Biologics Consumption CAGR by Region
    2.2 Biosimilars/Follow-on-Biologics Segment by Type
        2.2.1 Human Growth Hormone
        2.2.2 Erythropoietin
        2.2.3 Monoclonal Antibodies
        2.2.4 Insulin
        2.2.5 Interferon
        2.2.6 Granulocyte-Colony Stimulating Factor
        2.2.7 Peptide
        2.2.8 Others
    2.3 Biosimilars/Follow-on-Biologics Consumption by Type
        2.3.1 Global Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
        2.3.2 Global Biosimilars/Follow-on-Biologics Revenue and Market Share by Type (2015-2020)
        2.3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Type (2015-2020)
    2.4 Biosimilars/Follow-on-Biologics Segment by Application
        2.4.1 Blood Disorders
        2.4.2 Oncology Diseases
        2.4.3 Chronic and Autoimmune Diseases
        2.4.4 Growth Hormone Deficiencies
        2.4.5 Others
    2.5 Biosimilars/Follow-on-Biologics Consumption by Application
        2.5.1 Global Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020)
        2.5.2 Global Biosimilars/Follow-on-Biologics Value and Market Share by Type (2015-2020)
        2.5.3 Global Biosimilars/Follow-on-Biologics Sale Price by Type (2015-2020)

3 Global Biosimilars/Follow-on-Biologics by Company
    3.1 Global Biosimilars/Follow-on-Biologics Sales Market Share by Company
        3.1.1 Global Biosimilars/Follow-on-Biologics Sales by Company (2018-2020)
        3.1.2 Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2018-2020)
    3.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company
        3.2.1 Global Biosimilars/Follow-on-Biologics Revenue by Company (2018-2020)
        3.2.2 Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2018-2020)
    3.3 Global Biosimilars/Follow-on-Biologics Sale Price by Company
    3.4 Global Biosimilars/Follow-on-Biologics Manufacturing Base Distribution, Sales Area, Type by Company
        3.4.1 Global Biosimilars/Follow-on-Biologics Manufacturing Base Distribution and Sales Area by Company
        3.4.2 Players Biosimilars/Follow-on-Biologics Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 Biosimilars/Follow-on-Biologics by Regions
    4.1 Biosimilars/Follow-on-Biologics by Regions
    4.2 Americas Biosimilars/Follow-on-Biologics Consumption Growth
    4.3 APAC Biosimilars/Follow-on-Biologics Consumption Growth
    4.4 Europe Biosimilars/Follow-on-Biologics Consumption Growth
    4.5 Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Growth

5 Americas
    5.1 Americas Biosimilars/Follow-on-Biologics Consumption by Countries
        5.1.1 Americas Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
        5.1.2 Americas Biosimilars/Follow-on-Biologics Value by Countries (2015-2020)
    5.2 Americas Biosimilars/Follow-on-Biologics Consumption by Type
    5.3 Americas Biosimilars/Follow-on-Biologics Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
    5.8 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC Biosimilars/Follow-on-Biologics Consumption by Regions
        6.1.1 APAC Biosimilars/Follow-on-Biologics Consumption by Regions (2015-2020)
        6.1.2 APAC Biosimilars/Follow-on-Biologics Value by Regions (2015-2020)
    6.2 APAC Biosimilars/Follow-on-Biologics Consumption by Type
    6.3 APAC Biosimilars/Follow-on-Biologics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe Biosimilars/Follow-on-Biologics by Countries
        7.1.1 Europe Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
        7.1.2 Europe Biosimilars/Follow-on-Biologics Value by Countries (2015-2020)
    7.2 Europe Biosimilars/Follow-on-Biologics Consumption by Type
    7.3 Europe Biosimilars/Follow-on-Biologics Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa Biosimilars/Follow-on-Biologics by Countries
        8.1.1 Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020)
        8.1.2 Middle East & Africa Biosimilars/Follow-on-Biologics Value by Countries (2015-2020)
    8.2 Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Type
    8.3 Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 Biosimilars/Follow-on-Biologics Distributors
    10.3 Biosimilars/Follow-on-Biologics Customer

11 Global Biosimilars/Follow-on-Biologics Market Forecast
    11.1 Global Biosimilars/Follow-on-Biologics Consumption Forecast (2021-2025)
    11.2 Global Biosimilars/Follow-on-Biologics Forecast by Regions
        11.2.1 Global Biosimilars/Follow-on-Biologics Forecast by Regions (2021-2025)
        11.2.2 Global Biosimilars/Follow-on-Biologics Value Forecast by Regions (2021-2025)
        11.2.3 Americas Consumption Forecast
        11.2.4 APAC Consumption Forecast
        11.2.5 Europe Consumption Forecast
        11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
        11.3.1 United States Market Forecast
        11.3.2 Canada Market Forecast
        11.3.3 Mexico Market Forecast
        11.3.4 Brazil Market Forecast
   11.4 APAC Forecast by Countries
        11.4.1 China Market Forecast
        11.4.2 Japan Market Forecast
        11.4.3 Korea Market Forecast
        11.4.4 Southeast Asia Market Forecast
        11.4.5 India Market Forecast
        11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
        11.5.1 Germany Market Forecast
        11.5.2 France Market Forecast
        11.5.3 UK Market Forecast
        11.5.4 Italy Market Forecast
        11.5.5 Russia Market Forecast
    11.6 Middle East & Africa Forecast by Countries
        11.6.1 Egypt Market Forecast
        11.6.2 South Africa Market Forecast
        11.6.3 Israel Market Forecast
        11.6.4 Turkey Market Forecast
        11.6.5 GCC Countries Market Forecast
    11.7 Global Biosimilars/Follow-on-Biologics Forecast by Type
    11.8 Global Biosimilars/Follow-on-Biologics Forecast by Application

12 Key Players Analysis
    12.1 Novartis
        12.1.1 Company Information
        12.1.2 Biosimilars/Follow-on-Biologics Product Offered
        12.1.3 Novartis Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.1.4 Main Business Overview
        12.1.5 Novartis Latest Developments
    12.2 Genentech (Roche Group)
        12.2.1 Company Information
        12.2.2 Biosimilars/Follow-on-Biologics Product Offered
        12.2.3 Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.2.4 Main Business Overview
        12.2.5 Genentech (Roche Group) Latest Developments
    12.3 Synthon Pharmaceuticals
        12.3.1 Company Information
        12.3.2 Biosimilars/Follow-on-Biologics Product Offered
        12.3.3 Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.3.4 Main Business Overview
        12.3.5 Synthon Pharmaceuticals Latest Developments
    12.4 LG Life Sciences
        12.4.1 Company Information
        12.4.2 Biosimilars/Follow-on-Biologics Product Offered
        12.4.3 LG Life Sciences Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.4.4 Main Business Overview
        12.4.5 LG Life Sciences Latest Developments
    12.5 Celltrion
        12.5.1 Company Information
        12.5.2 Biosimilars/Follow-on-Biologics Product Offered
        12.5.3 Celltrion Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.5.4 Main Business Overview
        12.5.5 Celltrion Latest Developments
    12.6 Teva Pharmaceutical Industries
        12.6.1 Company Information
        12.6.2 Biosimilars/Follow-on-Biologics Product Offered
        12.6.3 Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.6.4 Main Business Overview
        12.6.5 Teva Pharmaceutical Industries Latest Developments
    12.7 Merck Group
        12.7.1 Company Information
        12.7.2 Biosimilars/Follow-on-Biologics Product Offered
        12.7.3 Merck Group Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.7.4 Main Business Overview
        12.7.5 Merck Group Latest Developments
    12.8 Biocon
        12.8.1 Company Information
        12.8.2 Biosimilars/Follow-on-Biologics Product Offered
        12.8.3 Biocon Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.8.4 Main Business Overview
        12.8.5 Biocon Latest Developments
    12.9 Biogen idec, Inc.
        12.9.1 Company Information
        12.9.2 Biosimilars/Follow-on-Biologics Product Offered
        12.9.3 Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.9.4 Main Business Overview
        12.9.5 Biogen idec, Inc. Latest Developments
    12.10 Hospira
        12.10.1 Company Information
        12.10.2 Biosimilars/Follow-on-Biologics Product Offered
        12.10.3 Hospira Biosimilars/Follow-on-Biologics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.10.4 Main Business Overview
        12.10.5 Hospira Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. Biosimilars/Follow-on-Biologics Consumption CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of Human Growth Hormone Table 5. Major Players of Erythropoietin Table 6. Major Players of Monoclonal Antibodies Table 7. Major Players of Insulin Table 8. Major Players of Interferon Table 9. Major Players of Granulocyte-Colony Stimulating Factor Table 10. Major Players of Peptide Table 11. Major Players of Others Table 12. Global Consumption Sales by Type (2015-2020) Table 13. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020) Table 14. Global Biosimilars/Follow-on-Biologics Revenue by Type (2015-2020) ($ million) Table 15. Global Biosimilars/Follow-on-Biologics Value Market Share by Type (2015-2020) ($ Millions) Table 16. Global Biosimilars/Follow-on-Biologics Sale Price by Type (2015-2020) Table 17. Global Consumption Sales by Application (2015-2020) Table 18. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020) Table 19. Global Biosimilars/Follow-on-Biologics Value by Application (2015-2020) Table 20. Global Biosimilars/Follow-on-Biologics Value Market Share by Application (2015-2020) Table 21. Global Biosimilars/Follow-on-Biologics Sale Price by Application (2015-2020) Table 22. Global Biosimilars/Follow-on-Biologics Sales by Company (2017-2019) (K Pcs) Table 23. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company (2017-2019) Table 24. Global Biosimilars/Follow-on-Biologics Revenue by Company (2017-2019) ($ Millions) Table 25. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company (2017-2019) Table 26. Global Biosimilars/Follow-on-Biologics Sale Price by Company (2017-2019) Table 27. Global Biosimilars/Follow-on-Biologics Manufacturing Base Distribution and Sales Area by Manufacturers Table 28. Players Biosimilars/Follow-on-Biologics Products Offered Table 29. Biosimilars/Follow-on-Biologics Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 30. Global Biosimilars/Follow-on-Biologics Consumption by Regions 2015-2020 (K Pcs) Table 31. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Regions 2015-2020 Table 32. Global Biosimilars/Follow-on-Biologics Value by Regions 2015-2020 ($ Millions) Table 33. Global Biosimilars/Follow-on-Biologics Value Market Share by Regions 2015-2020 Table 34. Americas Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020) (K Pcs) Table 35. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Countries (2015-2020) Table 36. Americas Biosimilars/Follow-on-Biologics Value by Countries (2015-2020) ($ Millions) Table 37. Americas Biosimilars/Follow-on-Biologics Value Market Share by Countries (2015-2020) Table 38. Americas Biosimilars/Follow-on-Biologics Consumption by Type (2015-2020) (K Pcs) Table 39. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020) Table 40. Americas Biosimilars/Follow-on-Biologics Consumption by Application (2015-2020) (K Pcs) Table 41. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020) Table 42. APAC Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020) (K Pcs) Table 43. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Countries (2015-2020) Table 44. APAC Biosimilars/Follow-on-Biologics Value by Regions (2015-2020) ($ Millions) Table 45. APAC Biosimilars/Follow-on-Biologics Value Market Share by Regions (2015-2020) Table 46. APAC Biosimilars/Follow-on-Biologics Consumption by Type (2015-2020) (K Pcs) Table 47. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020) Table 48. APAC Biosimilars/Follow-on-Biologics Consumption by Application (2015-2020) (K Pcs) Table 49. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020) Table 50. Europe Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020) (K Pcs) Table 51. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Countries (2015-2020) Table 52. Europe Biosimilars/Follow-on-Biologics Value by Countries (2015-2020) ($ Millions) Table 53. Europe Biosimilars/Follow-on-Biologics Value Market Share by Countries (2015-2020) Table 54. Europe Biosimilars/Follow-on-Biologics Consumption by Type (2015-2020) (K Pcs) Table 55. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020) Table 56. Europe Biosimilars/Follow-on-Biologics Consumption by Application (2015-2020) (K Pcs) Table 57. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020) Table 58. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Countries (2015-2020) (K Pcs) Table 59. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Countries (2015-2020) Table 60. Middle East & Africa Biosimilars/Follow-on-Biologics Value by Countries (2015-2020) ($ Millions) Table 61. Middle East & Africa Biosimilars/Follow-on-Biologics Value Market Share by Countries (2015-2020) Table 62. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Type (2015-2020) (K Pcs) Table 63. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020) Table 64. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption by Application (2015-2020) (K Pcs) Table 65. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020) Table 66. Biosimilars/Follow-on-Biologics Distributors List Table 67. Biosimilars/Follow-on-Biologics Customer List Table 68. Global Biosimilars/Follow-on-Biologics Consumption Forecast by Countries (2021-2025) (K Pcs) Table 69. Global Biosimilars/Follow-on-Biologics Consumption Market Forecast by Regions Table 70. Global Biosimilars/Follow-on-Biologics Value Forecast by Countries (2021-2025) ($ Millions) Table 71. Global Biosimilars/Follow-on-Biologics Value Market Share Forecast by Regions Table 72. Global Biosimilars/Follow-on-Biologics Consumption Forecast by Type (2021-2025) (K Pcs) Table 73. Global Biosimilars/Follow-on-Biologics Consumption Market Share Forecast by Type (2021-2025) Table 74. Global Biosimilars/Follow-on-Biologics Value Forecast by Type (2021-2025) ($ Millions) Table 75. Global Biosimilars/Follow-on-Biologics Value Market Share Forecast by Type (2021-2025) Table 76. Global Biosimilars/Follow-on-Biologics Consumption Forecast by Application (2021-2025) (K Pcs) Table 77. Global Biosimilars/Follow-on-Biologics Consumption Market Share Forecast by Application (2021-2025) Table 78. Global Biosimilars/Follow-on-Biologics Value Forecast by Application (2021-2025) ($ Millions) Table 79. Global Biosimilars/Follow-on-Biologics Value Market Share Forecast by Application (2021-2025) Table 80. Novartis Product Offered Table 81. Novartis Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 82. Novartis Main Business Table 83. Novartis Latest Developments Table 84. Novartis Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 85. Genentech (Roche Group) Product Offered Table 86. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 87. Genentech (Roche Group) Main Business Table 88. Genentech (Roche Group) Latest Developments Table 89. Genentech (Roche Group) Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 90. Synthon Pharmaceuticals Product Offered Table 91. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 92. Synthon Pharmaceuticals Main Business Table 93. Synthon Pharmaceuticals Latest Developments Table 94. Synthon Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 95. LG Life Sciences Product Offered Table 96. LG Life Sciences Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 97. LG Life Sciences Main Business Table 98. LG Life Sciences Latest Developments Table 99. LG Life Sciences Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 100. Celltrion Product Offered Table 101. Celltrion Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 102. Celltrion Main Business Table 103. Celltrion Latest Developments Table 104. Celltrion Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 105. Teva Pharmaceutical Industries Product Offered Table 106. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 107. Teva Pharmaceutical Industries Main Business Table 108. Teva Pharmaceutical Industries Latest Developments Table 109. Teva Pharmaceutical Industries Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 110. Merck Group Product Offered Table 111. Merck Group Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 112. Merck Group Main Business Table 113. Merck Group Latest Developments Table 114. Merck Group Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 115. Biocon Product Offered Table 116. Biocon Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 117. Biocon Main Business Table 118. Biocon Latest Developments Table 119. Biocon Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 120. Biogen idec, Inc. Product Offered Table 121. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 122. Biogen idec, Inc. Main Business Table 123. Biogen idec, Inc. Latest Developments Table 124. Biogen idec, Inc. Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors Table 125. Hospira Product Offered Table 126. Hospira Biosimilars/Follow-on-Biologics Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2020E) Table 127. Hospira Main Business Table 128. Hospira Latest Developments Table 129. Hospira Basic Information, Company Total Revenue (in $ million), Biosimilars/Follow-on-Biologics Manufacturing Base, Sales Area and Its Competitors List of Figures Figure 1. Picture of Biosimilars/Follow-on-Biologics Figure 2. Biosimilars/Follow-on-Biologics Report Years Considered Figure 3. Market Research Methodology Figure 4. Global Biosimilars/Follow-on-Biologics Consumption Growth Rate 2015-2025 (K Pcs) Figure 5. Global Biosimilars/Follow-on-Biologics Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of Human Growth Hormone Figure 7. Product Picture of Erythropoietin Figure 8. Product Picture of Monoclonal Antibodies Figure 9. Product Picture of Insulin Figure 10. Product Picture of Interferon Figure 11. Product Picture of Granulocyte-Colony Stimulating Factor Figure 12. Product Picture of Peptide Figure 13. Product Picture of Others Figure 14. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Type (2015-2020) Figure 15. Global Biosimilars/Follow-on-Biologics Value Market Share by Type (2015-2020) Figure 16. Biosimilars/Follow-on-Biologics Consumed in Blood Disorders Figure 17. Global Biosimilars/Follow-on-Biologics Market: Blood Disorders (2015-2020) (K Pcs) Figure 18. Global Biosimilars/Follow-on-Biologics Market: Blood Disorders (2015-2020) ($ Millions) Figure 19. Biosimilars/Follow-on-Biologics Consumed in Oncology Diseases Figure 20. Global Biosimilars/Follow-on-Biologics Market: Oncology Diseases (2015-2020) (K Pcs) Figure 21. Global Biosimilars/Follow-on-Biologics Market: Oncology Diseases (2015-2020) ($ Millions) Figure 22. Biosimilars/Follow-on-Biologics Consumed in Chronic and Autoimmune Diseases Figure 23. Global Biosimilars/Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2015-2020) (K Pcs) Figure 24. Global Biosimilars/Follow-on-Biologics Market: Chronic and Autoimmune Diseases (2015-2020) ($ Millions) Figure 25. Biosimilars/Follow-on-Biologics Consumed in Growth Hormone Deficiencies Figure 26. Global Biosimilars/Follow-on-Biologics Market: Growth Hormone Deficiencies (2015-2020) (K Pcs) Figure 27. Global Biosimilars/Follow-on-Biologics Market: Growth Hormone Deficiencies (2015-2020) ($ Millions) Figure 28. Biosimilars/Follow-on-Biologics Consumed in Others Figure 29. Global Biosimilars/Follow-on-Biologics Market: Others (2015-2020) (K Pcs) Figure 30. Global Biosimilars/Follow-on-Biologics Market: Others (2015-2020) ($ Millions) Figure 31. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Application (2015-2020) Figure 32. Global Biosimilars/Follow-on-Biologics Value Market Share by Application (2015-2020) Figure 33. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company in 2017 Figure 34. Global Biosimilars/Follow-on-Biologics Sales Market Share by Company in 2019 Figure 35. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company in 2017 Figure 36. Global Biosimilars/Follow-on-Biologics Revenue Market Share by Company in 2019 Figure 37. Global Biosimilars/Follow-on-Biologics Sale Price by Company in 2019 Figure 38. Global Biosimilars/Follow-on-Biologics Consumption Market Share by Regions 2015-2020 Figure 39. Global Biosimilars/Follow-on-Biologics Value Market Share by Regions 2015-2020 Figure 40. Americas Biosimilars/Follow-on-Biologics Consumption 2015-2020 (K Pcs) Figure 41. Americas Biosimilars/Follow-on-Biologics Value 2015-2020 ($ Millions) Figure 42. APAC Biosimilars/Follow-on-Biologics Consumption 2015-2020 (K Pcs) Figure 43. APAC Biosimilars/Follow-on-Biologics Value 2015-2020 ($ Millions) Figure 44. Europe Biosimilars/Follow-on-Biologics Consumption 2015-2020 (K Pcs) Figure 45. Europe Biosimilars/Follow-on-Biologics Value 2015-2020 ($ Millions) Figure 46. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption 2015-2020 (K Pcs) Figure 47. Middle East & Africa Biosimilars/Follow-on-Biologics Value 2015-2020 ($ Millions) Figure 48. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2019 Figure 49. Americas Biosimilars/Follow-on-Biologics Value Market Share by Countries in 2019 Figure 50. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Type in 2019 Figure 51. Americas Biosimilars/Follow-on-Biologics Consumption Market Share by Application in 2019 Figure 52. United States Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 53. United States Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 54. Canada Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 55. Canada Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 56. Mexico Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 57. Mexico Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 58. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2019 Figure 59. APAC Biosimilars/Follow-on-Biologics Value Market Share by Regions in 2019 Figure 60. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Type in 2019 Figure 61. APAC Biosimilars/Follow-on-Biologics Consumption Market Share by Application in 2019 Figure 62. China Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 63. China Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 64. Japan Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 65. Japan Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 66. Korea Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 67. Korea Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 68. Southeast Asia Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 69. Southeast Asia Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 70. India Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 71. India Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 72. Australia Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 73. Australia Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 74. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2019 Figure 75. Europe Biosimilars/Follow-on-Biologics Value Market Share by Countries in 2019 Figure 76. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Type in 2019 Figure 77. Europe Biosimilars/Follow-on-Biologics Consumption Market Share by Application in 2019 Figure 78. Germany Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 79. Germany Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 80. France Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 81. France Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 82. UK Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 83. UK Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 84. Italy Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 85. Italy Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 86. Russia Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 87. Russia Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 88. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Countries in 2019 Figure 89. Middle East & Africa Biosimilars/Follow-on-Biologics Value Market Share by Countries in 2019 Figure 90. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Type in 2019 Figure 91. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption Market Share by Application in 2019 Figure 92. Egypt Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 93. Egypt Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 94. South Africa Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 95. South Africa Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 96. Israel Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 97. Israel Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 98. Turkey Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 99. Turkey Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 100. GCC Countries Biosimilars/Follow-on-Biologics Consumption Growth 2015-2020 (K Pcs) Figure 101. GCC Countries Biosimilars/Follow-on-Biologics Value Growth 2015-2020 ($ Millions) Figure 102. Global Biosimilars/Follow-on-Biologics Consumption Growth Rate Forecast (2021-2025) (K Pcs) Figure 103. Global Biosimilars/Follow-on-Biologics Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 104. Americas Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 105. Americas Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 106. APAC Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 107. APAC Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 108. Europe Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 109. Europe Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 110. Middle East & Africa Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 111. Middle East & Africa Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 112. United States Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 113. United States Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 114. Canada Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 115. Canada Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 116. Mexico Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 117. Mexico Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 118. Brazil Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 119. Brazil Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 120. China Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 121. China Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 122. Japan Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 123. Japan Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 124. Korea Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 125. Korea Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 126. Southeast Asia Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 127. Southeast Asia Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 128. India Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 129. India Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 130. Australia Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 131. Australia Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 132. Germany Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 133. Germany Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 134. France Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 135. France Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 136. UK Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 137. UK Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 138. Italy Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 139. Italy Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 140. Russia Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 141. Russia Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 142. Spain Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 143. Spain Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 144. Egypt Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 145. Egypt Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 146. South Africa Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 147. South Africa Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 148. Israel Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 149. Israel Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 150. Turkey Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 151. Turkey Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 152. GCC Countries Biosimilars/Follow-on-Biologics Consumption 2021-2025 (K Pcs) Figure 153. GCC Countries Biosimilars/Follow-on-Biologics Value 2021-2025 ($ Millions) Figure 154. Novartis Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 155. Genentech (Roche Group) Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 156. Synthon Pharmaceuticals Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 157. LG Life Sciences Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 158. Celltrion Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 159. Teva Pharmaceutical Industries Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 160. Merck Group Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 161. Biocon Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 162. Biogen idec, Inc. Biosimilars/Follow-on-Biologics Market Share (2018-2020) Figure 163. Hospira Biosimilars/Follow-on-Biologics Market Share (2018-2020)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by LP Information Inc

Global Analog KVM Switches Market Growth 2020-2025

According to this study, over the next five years the Analog KVM Switches market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the...

Global Digital KVM Switches Market Growth 2020-2025

According to this study, over the next five years the Digital KVM Switches market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents th...

Global Non-rechargeable Lithium Battery Market Growth 2020-2025

According to this study, over the next five years the Non-rechargeable Lithium Battery market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report...

Global Non-rechargeable Flexible Battery Market Growth 2020-2025

According to this study, over the next five years the Non-rechargeable Flexible Battery market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this repor...

Global Tactile Feedback Actuators Market Growth 2020-2025

According to this study, over the next five years the Tactile Feedback Actuators market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report prese...

Publisher: LP Information Inc
Chat with us